Prenosis, a Leader in AI-Driven Precision Medicine, Wins Prestigious TIME Award for Transforming Sepsis Diagnosis with Its FDA-Authorized Sepsis ImmunoScore™ CHICAGO , Oct. 30, 2024 /PRNewswire/ — Today, Prenosis Inc.’s Sepsis ImmunoScore™ was named one of...
Prenosis Announces Commercial Distribution Collaboration with Roche for Sepsis ImmunoScore™
Prenosis will collaborate with Roche to bring the Sepsis ImmunoScoreTM to hospitals across the United States on Roche’s navify® Algorithm Suite platform CHICAGO, April 10, 2024 /PRNewswire/ — Today, Prenosis, Inc., an artificial intelligence company...
Prenosis Announces FDA De Novo Marketing Authorization of the Sepsis ImmunoScoreTM
The Sepsis ImmunoScoreTM is the first-ever AI Sepsis Diagnostic granted marketing authorization by the FDA. CHICAGO, April 3, 2024 /PRNewswire/ — Prenosis, Inc., an artificial intelligence company enabling precision medicine in acute care, today announced the...
Prenosis Inc. Appoints Leadership Team for Commercialization In Hospitals
AI health tech company—the world leader in data and insights for abnormal immune response in acute care—expands its executive team and adds additional sepsis clinical expert to its advisory board CHICAGO, Oct. 4, 2023 /PRNewswire/ — Prenosis, Inc., an artificial...